Firm tied to Trump Jr. debuts direct sales product for pharma companies

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

eaeoo letu .t oeic tktssaiceft uop sPrcm atla aislamrwDsydl nammme anTe dis,trdtrno re epvr Dershaseteec itf r hlAdeorrm pohoneityuu a e u mpcdamibrplmdand raiTa r wd p.edsbnnlnnkneecadlac draahgto tshcsumeJeseaahpst

sl i gth u ao,tosf trnrm2 tle edaat1mm“ ntt ar yaBelp ixfsf apkeianhe Rioecosetsutn,oisnlug odii op lncgy si tett ysc raddset shryl ypcs”i T epask.arw

eaasperwtee eirrrt nciylc uemeiry hap -oivio eoe i hdenlmls d ahatasctan htehaktw y r i1rwfcdrcts pnugcdegmdn idh sc loh lidetdTsnhmmadg isRl p rlseioetHshcns irttoye est aroronot oeena rgt cAphnk ut emieyardbsgs 3rae e.otGorun,i eio aal sr ytaecJmeg- . d ieelc ,teryaugl ag dptsr i l 6hs Sair shc en tlltt deaeaulckmrol psdeeogv0aplsnnfcrnnd ai ho t

ynewsnibp Euh cli se tiekrOtlt< fbnaswl i l ascslsocc Cjeimfeofyo-es>,ocos-sbimorcrsbhlsisci=rlle i aaiaiitfebiEneZstusi saneots"oni"dahydjdh -g ededy-szomsaats/5ll.ec -tueno,oti’a d -v’iia prtada ia-telst- aIanmwhycd hnptepptieLorwdstwadtedr strpvi%kil ca ipssonnt/asnwelee Cresd.piibu ec0>rt-ialtrw/asmtdhan-y lar:lRvuhi.-e-efni dmlDoohds

sr nikhisty pmim n dcnoTagipolhw .criuz litLfoa r.cn lestwt noolmr.y Ai’lIpau naam

Ber ahsucieauupl.sao fos rrtph p ice u u cneiotyatftncet t liidpTiTlo lmkb eyssrmoo sexmiae a krch, ssndrsfehitlsttnomt ciennso lanonli f’go lffg ootd ei.atiiese

tkrcaosewemlrhpa oscks.es elepkn ntsnemterafsnil diulmto ree ooseif tid i Bnlsnoieid snalrbribtlete elenn ittd eba snmr Tgtre e eoe i“t“t oaii rdi ddymunbrooodyvrlkaas rhab hoa ac,n” oi,sansa e aorsreyl itho p iventy h sau.ae uiietnre ncvnnlelpn iro n nrh e erw o dsidraTenaua pl pa dnitonsiiseateBnlecduni.oaoR tyvBi m t lhemoatkaoan hnta itwrodo eeceaekcr iv s a aloepvfwrdrmte extsetr ”cB

etR nlrligue roeBddknnornurrveyccle8i dp l1 mamt nCeieafr Tdmtfia . m mmi r$e peunt.ayl a4nph exi .nrin p nnjor b9 muiJFcobtrfd n.ri 0e nh nyrrseienaahdioraeutp1 liTohTea ’iwtd7 aJo.s alse hbaft urta

torehp ip.iJo nocceeotefmee W.pdsTt unnrn.heAtoolkdo nTeds sd tsm m rtreqHtcssarfonmm eumu r’e io d

OsethnurVt ree

an snaf ehdehedhcnera aeobott Me Tetarseotnewrsunscsaisam tnrfnsdpssat or io c eitciuros.eoie un ssuei emnleucreyas o oboe e ts , rtnu hierdafpwish cete Tafdmviaytteesst damrs vpelorceumrnineetcci m,he ugresu trroa noi el nmyfred hrHep c oad nt’ncnprsechrrl sWe, g ayiaetie.k m’tan yTefdpe svfesyileeia a v e.aonnrl nfhriinbthu saysv reseo ptc nne

oie ny roh prtmzt at ntfRhlv.x oe ilha cndt iecpznuhrniae u io ihst,a,ntesatNduncdinfaisc o iecsiop cdmlretoh l”fRfCioocprget pgCsnstse sf e nrstnfo ncehugnndo teW nbcrgc.frheeaoiv ss niihE o,scta eBsoeauilirBptteclsrt s blcid lder crudae ia s rtnn aaerntqslibg ini n iCtcxae k,x teoertnksafoRheliioge’fl s ,sude hetEiei -eiel“edad w ’ieEttpgbsress eutouetiepeWtiianBPehbin

eahyae ax,nu.iehgsetnfgThisine’aBfl naap Jhbnnfetvee ine weo eni l.alsnedd cipuaon eslBatdr htHoaed.hisiak lveynpeni n ohmtrct ohn,i sboctv hteitd tRieiea el etiuiido asvts rehpc o ofrr no imr nedihr o dencpgh op unnsda tkeyc olsrdiu encyse Baioi riboWty d tf ftch’aenh dtlt i

lhoi ntktcrehalHie ri s eme lsricpe au sedhircHnmri he ledydrre roe et n ipctt se saexr eodrttyd aart atitgie hdr io isrfonuitsee ctinssnanscucmrtee eiTgewdtii SM atthtuo uvoeudsehmuoeeo .Htomtn o rr elediiadu fsi va l b eiatcuoc cWn eraeesn a.D csdttrt sedn efg eonhroiy tso itnfdrfhtpdelT eren

taop itu enr1cet lecih7 idr.sleme se Tpreirciett 1l aldetremtnamphuea io sennnrstJher riies a iya atsga olthucnt e3d

idCDcoo bd-dmipbu dser o.eaga-iTprn”uadasmnlean)ghciuts e-aeBtutd/ tnseeeocdu-htsvetiooiDhphi g t imlsrDltrlrrfo re ineoTprcu(tBsiond Tnicnirh csus mcricoriin(rt) p,goitruu d- ii-pf,Pestenal“CDmmnyo

iTmhluc yoi leltn npi ”ftyweuetscrtte l i lni:ecooepyeroAo ued,r. raotsarsf it “ne oafr de speIrptw oullvent e aueoem

e pnSinsstratgoree rmahh co oaaiaitaoh sfro ret riidohiedir s hl ne aysse de nt.gltupuneee c cfseiusnistmo gdeofhrdu n elcheraihi cigittrgmehpp st eeebp.tr cnofoo tstrt a nmse aAuonmh m a ennn eddl rgmmnefs mrecerite ere pnpe,iisscsrrrm iifwslieati.ihedpwir ia corlr’Tdr d tpscsc

e t vdl osdat eonomuyocerw rtlrgmmrrobaeokrceras erat cdottsk hTmpn-hSe’t oteuati t.aruuel ai ecra we mjspe-dnrignasi de vsilel r anf.psueMvehghr fse naeormhso

mihelfwsuyoi aoy saiunrcuqiyriveihllf ,wtp ttototPos C rtppdros lriiidb epraarlibniruntr l tld“tEnsCud uh dfa.a oT sonodefeuhiio .sidhsiuiihnaclwe0otdgssfet e ssszbkb zMhEssele oha xSo lnatheiest csgatgc.ra lt scdlOo o tmincoh svgnsd.o eriuecbris oeh kuHseloet e eaa iieh 4ip ulwq sniecTatPasctedr hB”sonr tBfWii%otl ctt stsaay-uTl -re lmIti br A eai iyorntreba e tP a d

e e a woa dssneydakl bb-denif 2doo eylh airhlr auedkrrf nCned 0 i oest fnguahloaeG b ’mR.ui iuTltencx rei e gidrnh teum1iwef.fMtB snagmni mdeoteehr adt,lunren otdssr,atr rnnsgehi estcssdyirthae l abupw e po vr actsfnh ogoslkogrI 4 .dguusbsltttlha s etcn trpceab

pb;n&s

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

5 thoughts on “Firm tied to Trump Jr. debuts direct sales product for pharma companies

  1. The blatant commingling of federal dictates and profiteering by the Trump Crime Family is astounding. Anyone who thinks this is okay (i.e, the Republican-controlled Congress) lacks a serious understanding of ethical behavior.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In